Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Gen Comp Endocrinol. 2014 Mar 30;0:215–224. doi: 10.1016/j.ygcen.2014.03.029

Fig. 5.

Fig. 5

Disease-associated gene networks related to differentially regulated genes altered in whole brain of female largemouth bass (LMB) at the high-MeHg field site. Red indicates increased gene expression at the high-MeHg field site while green indicates that gene expression is decreased at the high-MeHg field site. Abbreviations: ABCB7: ATP-binding cassette, sub-family B (MDR/TAP), member 7; AMACR: alpha-methylacyl-CoA racemase; CASP3: caspase 3, apoptosis-related cysteine peptidase; CAT: catalase; CDC73: cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae); CLDN4: claudin 4; CP: ceruloplasmin (ferroxidase); CREB1: cAMP responsive element binding protein 1; CTSD: cathepsin D; CYP24A1: cytochrome P450, family 24, subfamily A, polypeptide 1; ESR1: estrogen receptor 1; ESR2: estrogen receptor 2 (ER beta); F2: coagulation factor II (thrombin); FGA: fibrinogen alpha chain; GAD1: glutamate decarboxylase 1 (brain, 67 kDa); GAD2: glutamate decarboxylase 2 (pancreatic islets and brain, 65 kDa); GH1: growth hormone 1; GNAQ: guanine nucleotide binding protein (G protein), q polypeptide; HSPA8: heat shock 70 kDa protein 8; IGF1: insulin-like growth factor 1 (somatomedin C); KDR: kinase insert domain receptor (a type III receptor tyrosine kinase); LYZ: lysozyme; MBP: myelin basic protein; NPY: neuropeptide Y; PARP1: poly (ADP-ribose) polymerase 1; PLG: plasminogen; POMC: proopiomelanocortin; PPARG: peroxisome proliferator-activated receptor gamma; PRDX4: peroxiredoxin 4; PRL: prolactin; SERPINC1: serpin peptidase inhibitor, clade C (antithrombin), member 1; SGCE: sarcoglycan, epsilon; STC1: stanniocalcin 1; TBP: TATA box binding protein; TGFB1: transforming growth factor, beta 1; TPT1: tumor protein, translationally-controlled 1; VEGFA: vascular endothelial growth factor A.